A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) remains the most frequent liver cancer, accounting for approximately 90% of primary liver cancers worldwide. The recurrence-free survival (RFS) of HCC patients is a critical factor in devising a personal treatment plan. Thus, it is necessary to accurately f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenhua, Wang, Lingchen, Xie, Xinsheng, Yan, Yehong, Li, Yue, Lu, Quqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786458/
https://www.ncbi.nlm.nih.gov/pubmed/33402113
http://dx.doi.org/10.1186/s12885-020-07692-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786458/
https://www.ncbi.nlm.nih.gov/pubmed/33402113
http://dx.doi.org/10.1186/s12885-020-07692-6

Ejemplares similares